{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:06:19Z","timestamp":1770897979276,"version":"3.50.1"},"reference-count":21,"publisher":"SLACK, Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmic Surg Lasers Imaging Retina"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This study aimed to evaluate characteristics of industry and public research payments for age-related macular degeneration studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>Studies involving \u201cage-related macular degeneration\u201d or \u201cAMD\u201d from 2015 to 2021 were extracted from the Open Payments Database and the National Eye Institute RePORTER tool and compared to each other.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>\n              From 2015 to 2021, 620 ophthalmologists received $178,394,734.09 in industry research payments with a 76.9% increase from 2015 to 2020 and a subsequent 40.7% decrease in 2021. There were 84 female industry funding recipients (13.7%) compared to 528 (86.3%) male recipients (\n              <jats:italic>P<\/jats:italic>\n              &lt; 0.001). For public funding, 119 ophthalmologists received $157,319,575.00 with a 31.0% increase from 2015 to 2021. Among 119 principal investigators, 37 (31.1%) were women and 82 (68.9%) were men (\n              <jats:italic>P<\/jats:italic>\n              = 0.05).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Industry-funded and publicly funded age-related macular degeneration\u2013related research payments overall increased from 2015 to 2021. Funding distribution by sex trended towards male recipients.<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                [\n                <jats:italic>Ophthalmic Surg Lasers Imaging Retina<\/jats:italic>\n                2025;56:95\u2013100.]\n              <\/jats:bold>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/23258160-20240903-01","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T12:52:18Z","timestamp":1727095938000},"page":"95-100","source":"Crossref","is-referenced-by-count":1,"title":["Trends in Research Payments for Age-related Macular Degeneration From 2015 to 2021"],"prefix":"10.3928","volume":"56","author":[{"given":"April M.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy T.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.01.003"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29583"},{"issue":"3","key":"e_1_3_1_4_2","first-page":"353","article-title":"Age-related macular degeneration (AMD): pathogenesis and therapy","volume":"58","author":"Nowak JZ","year":"2006","unstructured":"Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58(3):353\u2013363. PMID:16845209","journal-title":"Pharmacol Rep"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.5576"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.3986"},{"key":"e_1_3_1_7_2","volume-title":"About Open Payments Data","unstructured":"About Open Payments Data. Centers for Medicare & Medicaid Services. Accessed December 20, 2023. https:\/\/open-paymentsdata.cms.gov\/about."},{"key":"e_1_3_1_8_2","volume-title":"NIH RePORT Search","unstructured":"NIH RePORT Search. National Institutes of Health. Accessed February 26, 2023. https:\/\/reporter.nih.gov\/."},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.04.028"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.3126\/nje.v10i3.31622"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.3729"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2016.2257"},{"key":"e_1_3_1_13_2","volume-title":"WinR Mentoring Program","unstructured":"WinR Mentoring Program. American Society of Retina Specialists. Accessed June 30, 2023. https:\/\/www.asrs.org\/sections\/women-in-retina\/winr-mentoring-program."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9945725"},{"key":"e_1_3_1_15_2","unstructured":"Study to compare the efficacy and safety of intravitreal APL-2 therapy with sham injections in patients with geographic atrophy (GA) secondary to age-related macular degeneration. ClinicalTrials.gov. Accessed June 30 2023. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03525600"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01844-5"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317434"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.12.031"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.21037\/aes-21-45"},{"key":"e_1_3_1_20_2","unstructured":"Safety tolerability and efficacy of aflibercept in patients with neovascular age-related macular degeneration (CANDELA). ClinicalTrials.gov. Accessed June 30 2023. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04126317."},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2020.11.004"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.08.001"}],"container-title":["Ophthalmic Surgery, Lasers and Imaging Retina"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T18:21:10Z","timestamp":1739384470000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/23258160-20240903-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.3928\/23258160-20240903-01"],"URL":"https:\/\/doi.org\/10.3928\/23258160-20240903-01","relation":{},"ISSN":["2325-8160","2325-8179"],"issn-type":[{"value":"2325-8160","type":"print"},{"value":"2325-8179","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}